Eradicating TB in India: Its up to you Ranbaxy

In what could be an interesting example of a Public-Private Partnership in the pharmaceutical sector, India’s largest drug-maker has entered into an agreement with the Department of Biotechnology to push for discovering new drugs to treat tuberculosis. The Department of Biotechnology will provide a three-year grant to Ranbaxy as per the agreement to conduct research and develop drugs [via iGovernment]

The agreement is an important step in tackling India’s TB epidemic. As we had reported in the space before, India is home to 20% of the world’s multiple drug resistant tuberculosis (MDRTB) patients, carrying one-third of the disease burden globally.